Skip to content

Acne Study 2026

Moderate to Severe Acne Vulgaris Study

WDC is participating as a clinical trial site to evaluate the safety and effectiveness of a study medication in participants with moderate to severe acne vulgaris. This survey is designed to assist our research team in identifying potential candidates for this study. Please answer all questions honestly and WDC research staff will respond to you with potential next steps during our pre-screening process.
1.Please provide your full name.
2.Enter your email address or preferred contact number.
3.Are you or your child in consideration of this study at least 12 years of age or older?
4.Do you have moderate to severe acne with at least 60 active acne lesions?
5.Are you willing and able to discontinue all topical and oral acne treatments for the duration of the clinical trial?
6.Do you have cystic acne?